Klaase JM - Search Results

1

Regional isolated perfusion with melphalan for patients with subungual melanoma.

Vrouenraets BC, Kroon BB, Klaase JM, van Geel BN, Eggermont AM, Mooi WJ, van Dongen JA. Vrouenraets BC, et al. Among authors: klaase jm. Eur J Surg Oncol. 1993 Feb;19(1):37-42. Eur J Surg Oncol. 1993. PMID: 8436239

2

The role of regional isolated perfusion in the eradication of melanoma micrometastases in the inguinal nodes: a comparison between an iliac and femoral perfusion procedure.

Klaase JM, Kroon BB, van Geel AN, Eggermont AM, Franklin HR, van Dongen JA. Klaase JM, et al. Melanoma Res. 1992 Dec;2(5-6):407-10. doi: 10.1097/00008390-199212000-00016. Melanoma Res. 1992. PMID: 1292788 Clinical Trial.

3

Surgery for melanoma metastatic to the gastrointestinal tract.

Klaase JM, Kroon BB. Klaase JM, et al. Br J Surg. 1990 Jan;77(1):60-1. doi: 10.1002/bjs.1800770121. Br J Surg. 1990. PMID: 1689196

4

Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities.

Klaase JM, Kroon BB, Benckhuijsen C, van Geel AN, Albus-Lutter CE, Wieberdink J. Klaase JM, et al. Cancer. 1989 Aug 1;64(3):616-21. doi: 10.1002/1097-0142(19890801)64:3<616::aid-cncr2820640309>3.0.co;2-8. Cancer. 1989. PMID: 2743257

5

[Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience].

Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B, Schmitz P. Lejeune F, et al. Bull Cancer. 1995 Jul;82(7):561-7. Bull Cancer. 1995. PMID: 7549119 French.

6

A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities.

Klaase JM, Kroon BB, Eggermont AM, van Geel AN, Schraffordt Koops H, Oldhoff J, Liénard D, Lejeune FJ, Berkel R, Franklin HR, et al. Klaase JM, et al. Eur J Cancer. 1995;31A(1):58-63. doi: 10.1016/0959-8049(94)00372-c. Eur J Cancer. 1995. PMID: 7695980

7

[Characteristics of patients with recurrence of primary melanoma at least 10 years following surgical treatment].

Klaase JM, Kroon BB. Klaase JM, et al. Ned Tijdschr Geneeskd. 1994 Dec 10;138(50):2488-91. Ned Tijdschr Geneeskd. 1994. PMID: 7800074 Dutch.

8

Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions.

Vrouenraets BC, Klaase JM, Kroon BB, van Geel BN, Eggermont AM, Franklin HR. Vrouenraets BC, et al. Among authors: klaase jm. Arch Surg. 1995 Jan;130(1):43-7. doi: 10.1001/archsurg.1995.01430010045009. Arch Surg. 1995. PMID: 7802575

9

Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma.

Lejeune F, Liénard D, Eggermont A, Schraffordt Koops H, Rosenkaimer F, Gérain J, Klaase J, Kroon B, Vanderveken J, Schmitz P. Lejeune F, et al. J Cell Biochem. 1994 Sep;56(1):52-61. doi: 10.1002/jcb.240560110. J Cell Biochem. 1994. PMID: 7806592 Review.

10

Comparison between the use of whole blood versus a diluted perfusate in regional isolated perfusion by continuous monitoring of transcutaneous oxygen tension: a pilot study.

Klaase JM, Kroon BB, van Slooten GW, van Dongen JA, van de Merwe SA, van der Zee J. Klaase JM, et al. J Invest Surg. 1994 May-Jun;7(3):249-58. doi: 10.3109/08941939409018290. J Invest Surg. 1994. PMID: 7918247 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

288 results

Search Page

Filters